U.S. Senator Ben Cardin Caps Off New Finance Speaker Series at the University of Maryland Smith School of Business
COLLEGE PARK, Md., May 8, 2024 /PRNewswire/ — Maryland U.S. Senator Ben Cardin discussed the challenges facing entrepreneurs and small business owners during the May 7 installment of the Finance Grand Challenges Speaker Series. Cardin is a senior member of the Senate Small Business & Entre
NUTEX HEALTH REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
TOTAL REVENUE OF $67.5 MILLION FOR FIRST QUARTER 2024 VS $56.3 MILLION IN 2023, AN INCREASE OF 20%HOSPITAL DIVISION VISITS OF 40,068 FOR THE FIRST QUARTER 2024 VS VISITS OF 33,085 IN 2023, AN INCREASE OF 21.1%HOSPITAL DIVISION OPERATING INCOME OF $10.5 MILLION FOR FIRST QUARTER 2024 VS $4.8 MILLION
GIVING TO UNIVERSITIES IN THE UK AND IRELAND REACHES AN ALL-TIME HIGH OF £1.37 BILLION IN FUNDS RECEIVED IN 2022-23
New funds received remain steady, resulting in the highest historical level for the second year running, according to the 2022-23 CASE Insights on Philanthropy (United Kingdom and Ireland) survey results LONDON, May 9, 2024 /PRNewswire/ — The CASE Insights on Philanthropy (United Kingdom a
DAVINCI LABORATORIES ISSUES ALLERGY ALERT ON UNDECLARED SHELLFISH ALLERGEN IN AMYLOID COMPLETE PRODUCT LOT 549853001
WILLISTON, Vt., May 8, 2024 /PRNewswire/ — DaVinci Laboratories, a division of FoodScience, LLC of Williston, Vermont is recalling 72 bottles of Amyloid Complete because it may contain undeclared shellfish (Shrimp and Crab). People who have an allergy or severe sensitivity to shellfish run the
ROSEN, THE FIRST FILING FIRM, Encourages Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – EVLV
NEW YORK, May 8, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. (NASDAQ: EVLV) between June 28, 2021 and March 13, 2024, both dates inclusive (the “Class
MINERVA FOODS RECORDS CONSOLIDATED GROSS REVENUE OF BRL 7.7 BILLION IN THE FIRST QUARTER OF 2024
EBITDA reached BRL 628.9 million and free cash flow was BRL 367 million in the period SÃO PAULO, May 9, 2024 /PRNewswire/ — Minerva Foods (Minerva S.A. – B3: BEEF3 | OTC – Nasdaq International: MRVSY), the leading exporter of fresh beef and its derivatives in South America, which also op
AgriBusiness Global™ Announces 2024 Event Line-Up: Connecting Crop Input Leaders Worldwide
WILLOUGHBY, Ohio, May 8, 2024 /PRNewswire/ — AgriBusiness Global, the premier business source for leaders in the global crop input value chain, is thrilled to announce its lineup of events for 2024. For 37 years, AgriBusiness Global has been the go-to resource for quality, trustworthy informat
Spectrum Control Announces New Direct RF Extension to SCi Blocks Family
— New DirectRF+™ Transceiver Extension Adds High-speed Digitization of up to Eight RF Inputs and Eight RF Outputs in 3U VPX Module to Support Next-generation Defense Systems — FREDERICK, Md., May 8, 2024 /PRNewswire/ — Spectrum Control Inc. announces a revolutionary new Direct RF exten
RE/MAX Elevates Commercial Business with 12th Annual Global Commercial Symposium
The annual RE/MAX Commercial event zeroes in on helping build Commercial Brokers’ business, June 10-12 in Tampa DENVER, May 8, 2024 /PRNewswire/ — RE/MAX, LLC, the #1 name in real estate1, announces the highly anticipated 2024 RE/MAX® Global Commercial Symposium, slated from June 10-12
Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
Ryan Confer Appointed Genprex President and CEO and to its Board of Directors AUSTIN, Texas, May 8, 2024 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for pa
